BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 27650929)

  • 1. The Cardioprotective Role of N-Acetyl Cysteine Amide in the Prevention of Doxorubicin and Trastuzumab-Mediated Cardiac Dysfunction.
    Goyal V; Bews H; Cheung D; Premecz S; Mandal S; Shaikh B; Best R; Bhindi R; Chaudhary R; Ravandi A; Thliveris J; Singal PK; Niraula S; Jassal DS
    Can J Cardiol; 2016 Dec; 32(12):1513-1519. PubMed ID: 27650929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congenital absence of nitric oxide synthase 3 potentiates cardiac dysfunction and reduces survival in doxorubicin- and trastuzumab-mediated cardiomyopathy.
    Zeglinski M; Premecz S; Lerner J; Wtorek P; Dasilva M; Hasanally D; Chaudhary R; Sharma A; Thliveris J; Ravandi A; Singal PK; Jassal DS
    Can J Cardiol; 2014 Mar; 30(3):359-67. PubMed ID: 24484915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Cardioprotective Role of Flaxseed in the Prevention of Doxorubicin- and Trastuzumab-Mediated Cardiotoxicity in C57BL/6 Mice.
    Asselin CY; Lam A; Cheung DYC; Eekhoudt CR; Zhu A; Mittal I; Mayba A; Solati Z; Edel A; Austria JA; Aukema HM; Ravandi A; Thliveris J; Singal PK; Pierce GN; Niraula S; Jassal DS
    J Nutr; 2020 Sep; 150(9):2353-2363. PubMed ID: 32510147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of renin angiotensin system antagonists in the prevention of doxorubicin and trastuzumab induced cardiotoxicity.
    Akolkar G; Bhullar N; Bews H; Shaikh B; Premecz S; Bordun KA; Cheung DY; Goyal V; Sharma AK; Garber P; Singal PK; Jassal DS
    Cardiovasc Ultrasound; 2015 Apr; 13():18. PubMed ID: 25889218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cardioprotective role of probucol against anthracycline and trastuzumab-mediated cardiotoxicity.
    Walker JR; Sharma A; Lytwyn M; Bohonis S; Thliveris J; Singal PK; Jassal DS
    J Am Soc Echocardiogr; 2011 Jun; 24(6):699-705. PubMed ID: 21353471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing Flaxseed and Perindopril in the Prevention of Doxorubicin and Trastuzumab-Induced Cardiotoxicity in C57Bl/6 Mice.
    Eekhoudt CR; Bortoluzzi T; Varghese SS; Cheung DYC; Christie S; Eastman S; Mittal I; Austria JA; Aukema HM; Ravandi A; Thliveris J; Singal PK; Jassal DS
    Curr Oncol; 2022 Apr; 29(5):2941-2953. PubMed ID: 35621631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxorubicin and trastuzumab regimen induces biventricular failure in mice.
    Milano G; Raucci A; Scopece A; Daniele R; Guerrini U; Sironi L; Cardinale D; Capogrossi MC; Pompilio G
    J Am Soc Echocardiogr; 2014 May; 27(5):568-79. PubMed ID: 24534652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overweight in mice, induced by perinatal programming, exacerbates doxorubicin and trastuzumab cardiotoxicity.
    Guenancia C; Hachet O; Aboutabl M; Li N; Rigal E; Cottin Y; Rochette L; Vergely C
    Cancer Chemother Pharmacol; 2016 Apr; 77(4):777-85. PubMed ID: 26914236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous administration of cardiac progenitor cell-derived exosomes protects against doxorubicin/trastuzumab-induced cardiac toxicity.
    Milano G; Biemmi V; Lazzarini E; Balbi C; Ciullo A; Bolis S; Ameri P; Di Silvestre D; Mauri P; Barile L; Vassalli G
    Cardiovasc Res; 2020 Feb; 116(2):383-392. PubMed ID: 31098627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acetylcysteine amide decreases oxidative stress but not cell death induced by doxorubicin in H9c2 cardiomyocytes.
    Shi R; Huang CC; Aronstam RS; Ercal N; Martin A; Huang YW
    BMC Pharmacol; 2009 Apr; 9():7. PubMed ID: 19368719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioprotective action of the aqueous extract of Terminalia arjuna bark against toxicity induced by doxorubicin.
    Bishop S; Liu SJ
    Phytomedicine; 2017 Dec; 36():210-216. PubMed ID: 29157817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catching broken hearts: pre-clinical detection of doxorubicin and trastuzumab mediated cardiac dysfunction in the breast cancer setting.
    Saeed MF; Premecz S; Goyal V; Singal PK; Jassal DS
    Can J Physiol Pharmacol; 2014 Jul; 92(7):546-50. PubMed ID: 24959994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic Evidence of MSCs-Derived Exosomes in Doxorubicin/Trastuzumab-Induced Cardiotoxicity: Beyond Mechanistic Target of NRG-1/Erb Signaling Pathway.
    Ebrahim N; Al Saihati HA; Mostafa O; Hassouna A; Abdulsamea S; Abd El Aziz M El Gebaly E; Abo-Rayah NH; Sabry D; El-Sherbiny M; Madboly AG; Hussien NI; Saadani REH; Ebrahim HA; Badr OAM; Elsherbiny NM; Salim RF
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of doxorubicin on the heart: From molecular mechanisms to intervention strategies.
    Prathumsap N; Shinlapawittayatorn K; Chattipakorn SC; Chattipakorn N
    Eur J Pharmacol; 2020 Jan; 866():172818. PubMed ID: 31758940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left Ventricular Global Longitudinal Strain in HER-2 + Breast Cancer Patients Treated with Anthracyclines and Trastuzumab Who Develop Cardiotoxicity Is Associated with Subsequent Recovery of Left Ventricular Ejection Fraction.
    Fei HW; Ali MT; Tan TC; Cheng KH; Salama L; Hua L; Zeng X; Halpern EF; Taghian A; MacDonald SM; Scherrer-Crosbie M
    Echocardiography; 2016 Apr; 33(4):519-26. PubMed ID: 26992012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anthracyclines/trastuzumab: new aspects of cardiotoxicity and molecular mechanisms.
    Rochette L; Guenancia C; Gudjoncik A; Hachet O; Zeller M; Cottin Y; Vergely C
    Trends Pharmacol Sci; 2015 Jun; 36(6):326-48. PubMed ID: 25895646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac protective effects of dexrazoxane on animal cardiotoxicity model induced by anthracycline combined with trastuzumab is associated with upregulation of calpain-2.
    Zhang S; Meng T; Liu J; Zhang X; Zhang J
    Medicine (Baltimore); 2015 Jan; 94(4):e445. PubMed ID: 25634181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoceria ameliorates doxorubicin induced cardiotoxicity: Possible mitigation via reduction of oxidative stress and inflammation.
    Sangomla S; Saifi MA; Khurana A; Godugu C
    J Trace Elem Med Biol; 2018 May; 47():53-62. PubMed ID: 29544808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxorubicin-induced and trastuzumab-induced cardiotoxicity in mice is not prevented by metoprolol.
    Nicol M; Sadoune M; Polidano E; Launay JM; Samuel JL; Azibani F; Cohen-Solal A
    ESC Heart Fail; 2021 Apr; 8(2):928-937. PubMed ID: 33529501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac autonomic modulation induced by doxorubicin in a rodent model of colorectal cancer and the influence of fullerenol pretreatment.
    Potočnik N; Perše M; Cerar A; Injac R; Finderle Ž
    PLoS One; 2017; 12(7):e0181632. PubMed ID: 28727839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.